<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02876757</url>
  </required_header>
  <id_info>
    <org_study_id>2016 0906 192 000</org_study_id>
    <nct_id>NCT02876757</nct_id>
  </id_info>
  <brief_title>5 Alpha Reductase Inhibitors And The Risk Of Suicide And Depression</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Lawson Health Research Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Lawson Health Research Institute</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      In December 2015, Health Canada issued a warning about a potential relationship between
      suicide and finasteride use and called for further research. No population based studies have
      assessed the risk of suicide with finasteride use, and this risk is not currently part of the
      product monograph. Furthermore, the link between depression and finasteride has not been well
      studied in the older population who are the primary users of this medication.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2003</start_date>
  <completion_date type="Actual">March 2017</completion_date>
  <primary_completion_date type="Actual">December 2013</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Suicide (Based on Administrative Data Elements From Ontario Registrar General Death Database, National Ambulatory Care Reporting System, Hospital Discharge Abstracts, and Ontario Regional Mental Health Database)</measure>
    <time_frame>Through study completition, an average of 18 months.</time_frame>
    <description>Ontario Registrar General Death database. Use the COD_primary variable (used from 2003 onwards) to define suicide, based on an ICD10 code of X60-X84.
NACRS: X60-84 (dx10code1-dx10code10) AND dead on arrival or death after arrival (visdisp2002 = 10 or 11). Consider admission date the date of the event.
OMHRS: Discharge reason (dischreason (X90) = 2). Died from suicide. Consider admission date the date of the event.
CIHI-DAD (Consider admission date the date of the event):
i. suicide=1, or ii. dx10code1-25= ICD10 X60-84 AND dischdisp=&quot;07&quot;.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Suicide Attempt (Based on Administrative Data Elements From National Ambulatory Care Reporting System, and Ontario Regional Mental Health Database)</measure>
    <time_frame>Through study completition, an average of 18 months.</time_frame>
    <description>NACRS: presentation to the emergency room: ICD 10 codes X60-X84 (intentional self harm).
OMHRS: admission with suicide ideation.
i. Self injury attempts: D1A or selfinjury_attempt=3, 4, 5, or 6 ii. Self injury intent: D1B or selfinjury_intent=1 iii. Self injury considered: D1C or selfinjury_cons=3, 4, 5 or 6 iv. Self injury plan: D1DB or suicide_plan=1</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Depression (Based on Administrative Data Elements From Hospital Discharge Abstract Database, and Ontario Regional Mental Health Database and Ontario Health Insurance Plan)</measure>
    <time_frame>Through study completition, an average of 18 months.</time_frame>
    <description>Any CIHI-DAD/SDS ICD 10 code, OR
Any OMRHS code Axis1_dsm4code1-19 or Axis2_dsm4code 1-7 OR
Look for any OHIP record billed by Mainspecialty = &quot;PSYCHIATRY&quot; with a diagnosis of depression OHIP dxcode 311, OR
≥2 GP visits within 2 years AND both with OHIP dxcode 311
i. OHIP dxcode: 311 ii. ICD 10: F32.0, F32.1, F32.2, F32.3, F32.8, F32.9, F33.0, F33.1, F33.2, F33.3, F33.4, F33.8, F34.1 iii. Psychiatry visits defined as any of these OHIP fee codes: A195, A895, A190, A795, A695, A395, A196, A193, A194, A191, A192 iv. OMHRS: 29620-29626, 29630-29636, 31100 (major depressive disorder)</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">186394</enrollment>
  <condition>BPH</condition>
  <condition>Depression</condition>
  <condition>Suicide</condition>
  <arm_group>
    <arm_group_label>5ARI Users</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Non 5ARI users</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>5ARI</intervention_name>
    <description>Exposure to finasteride/dutasteride</description>
    <arm_group_label>5ARI Users</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        All men &gt;66 years of age in Ontario between 2003-2013
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All men &gt;66 years of age in Ontario between 2003-2013

        Exclusion Criteria:

          -  Non Ontario residents

          -  No prescriptions filled in prior 180 days

          -  Prior exposure to finasteride/dutasteride in the 2 years prior to study enrollment.

          -  Prescription initiated during hospital admission or ER visit.
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>66 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>June 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 5, 2016</study_first_submitted>
  <study_first_submitted_qc>August 18, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 24, 2016</study_first_posted>
  <results_first_submitted>April 12, 2017</results_first_submitted>
  <results_first_submitted_qc>July 19, 2017</results_first_submitted_qc>
  <results_first_posted type="Actual">February 5, 2018</results_first_posted>
  <last_update_submitted>July 19, 2017</last_update_submitted>
  <last_update_submitted_qc>July 19, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">February 5, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Depression</mesh_term>
    <mesh_term>Depressive Disorder</mesh_term>
    <mesh_term>Suicide</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>5-alpha Reductase Inhibitors</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>5ARI Users</title>
          <description>5ARI: Exposure to finasteride/dutasteride</description>
        </group>
        <group group_id="P2">
          <title>Non 5ARI Users</title>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="93197"/>
                <participants group_id="P2" count="93197"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="93197"/>
                <participants group_id="P2" count="93197"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>5ARI Users</title>
          <description>5ARI: Exposure to finasteride/dutasteride</description>
        </group>
        <group group_id="B2">
          <title>Non 5ARI Users</title>
          <description>Matched patients without 5ARI usage</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="93197"/>
            <count group_id="B2" value="93197"/>
            <count group_id="B3" value="186394"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="75.6" spread="6.7"/>
                    <measurement group_id="B2" value="75.5" spread="6.9"/>
                    <measurement group_id="B3" value="75.5" spread="6.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="93197"/>
                    <measurement group_id="B2" value="93197"/>
                    <measurement group_id="B3" value="186394"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Canada</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="93197"/>
                    <measurement group_id="B2" value="93197"/>
                    <measurement group_id="B3" value="186394"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Prior depression</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="3353"/>
                    <measurement group_id="B2" value="3353"/>
                    <measurement group_id="B3" value="6706"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Suicide (Based on Administrative Data Elements From Ontario Registrar General Death Database, National Ambulatory Care Reporting System, Hospital Discharge Abstracts, and Ontario Regional Mental Health Database)</title>
        <description>Ontario Registrar General Death database. Use the COD_primary variable (used from 2003 onwards) to define suicide, based on an ICD10 code of X60-X84.
NACRS: X60-84 (dx10code1-dx10code10) AND dead on arrival or death after arrival (visdisp2002 = 10 or 11). Consider admission date the date of the event.
OMHRS: Discharge reason (dischreason (X90) = 2). Died from suicide. Consider admission date the date of the event.
CIHI-DAD (Consider admission date the date of the event):
i. suicide=1, or ii. dx10code1-25= ICD10 X60-84 AND dischdisp=”07”.</description>
        <time_frame>Through study completition, an average of 18 months.</time_frame>
        <group_list>
          <group group_id="O1">
            <title>5ARI Users</title>
            <description>5ARI: Exposure to finasteride/dutasteride</description>
          </group>
          <group group_id="O2">
            <title>Non 5ARI Users</title>
          </group>
        </group_list>
        <measure>
          <title>Suicide (Based on Administrative Data Elements From Ontario Registrar General Death Database, National Ambulatory Care Reporting System, Hospital Discharge Abstracts, and Ontario Regional Mental Health Database)</title>
          <description>Ontario Registrar General Death database. Use the COD_primary variable (used from 2003 onwards) to define suicide, based on an ICD10 code of X60-X84.
NACRS: X60-84 (dx10code1-dx10code10) AND dead on arrival or death after arrival (visdisp2002 = 10 or 11). Consider admission date the date of the event.
OMHRS: Discharge reason (dischreason (X90) = 2). Died from suicide. Consider admission date the date of the event.
CIHI-DAD (Consider admission date the date of the event):
i. suicide=1, or ii. dx10code1-25= ICD10 X60-84 AND dischdisp=”07”.</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="93197"/>
                <count group_id="O2" value="93197"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="38"/>
                    <measurement group_id="O2" value="36"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Suicide Attempt (Based on Administrative Data Elements From National Ambulatory Care Reporting System, and Ontario Regional Mental Health Database)</title>
        <description>NACRS: presentation to the emergency room: ICD 10 codes X60-X84 (intentional self harm).
OMHRS: admission with suicide ideation.
i. Self injury attempts: D1A or selfinjury_attempt=3, 4, 5, or 6 ii. Self injury intent: D1B or selfinjury_intent=1 iii. Self injury considered: D1C or selfinjury_cons=3, 4, 5 or 6 iv. Self injury plan: D1DB or suicide_plan=1</description>
        <time_frame>Through study completition, an average of 18 months.</time_frame>
        <group_list>
          <group group_id="O1">
            <title>5ARI Users</title>
            <description>5ARI: Exposure to finasteride/dutasteride</description>
          </group>
          <group group_id="O2">
            <title>Non 5ARI Users</title>
          </group>
        </group_list>
        <measure>
          <title>Suicide Attempt (Based on Administrative Data Elements From National Ambulatory Care Reporting System, and Ontario Regional Mental Health Database)</title>
          <description>NACRS: presentation to the emergency room: ICD 10 codes X60-X84 (intentional self harm).
OMHRS: admission with suicide ideation.
i. Self injury attempts: D1A or selfinjury_attempt=3, 4, 5, or 6 ii. Self injury intent: D1B or selfinjury_intent=1 iii. Self injury considered: D1C or selfinjury_cons=3, 4, 5 or 6 iv. Self injury plan: D1DB or suicide_plan=1</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="93197"/>
                <count group_id="O2" value="93197"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="169"/>
                    <measurement group_id="O2" value="130"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Depression (Based on Administrative Data Elements From Hospital Discharge Abstract Database, and Ontario Regional Mental Health Database and Ontario Health Insurance Plan)</title>
        <description>Any CIHI-DAD/SDS ICD 10 code, OR
Any OMRHS code Axis1_dsm4code1-19 or Axis2_dsm4code 1-7 OR
Look for any OHIP record billed by Mainspecialty = “PSYCHIATRY” with a diagnosis of depression OHIP dxcode 311, OR
≥2 GP visits within 2 years AND both with OHIP dxcode 311
i. OHIP dxcode: 311 ii. ICD 10: F32.0, F32.1, F32.2, F32.3, F32.8, F32.9, F33.0, F33.1, F33.2, F33.3, F33.4, F33.8, F34.1 iii. Psychiatry visits defined as any of these OHIP fee codes: A195, A895, A190, A795, A695, A395, A196, A193, A194, A191, A192 iv. OMHRS: 29620-29626, 29630-29636, 31100 (major depressive disorder)</description>
        <time_frame>Through study completition, an average of 18 months.</time_frame>
        <population>This population is restricted to those who had no history of depression, thus it is a subgroup of the total study population.</population>
        <group_list>
          <group group_id="O1">
            <title>5ARI Users</title>
            <description>5ARI: Exposure to finasteride/dutasteride</description>
          </group>
          <group group_id="O2">
            <title>Non 5ARI Users</title>
          </group>
        </group_list>
        <measure>
          <title>Depression (Based on Administrative Data Elements From Hospital Discharge Abstract Database, and Ontario Regional Mental Health Database and Ontario Health Insurance Plan)</title>
          <description>Any CIHI-DAD/SDS ICD 10 code, OR
Any OMRHS code Axis1_dsm4code1-19 or Axis2_dsm4code 1-7 OR
Look for any OHIP record billed by Mainspecialty = “PSYCHIATRY” with a diagnosis of depression OHIP dxcode 311, OR
≥2 GP visits within 2 years AND both with OHIP dxcode 311
i. OHIP dxcode: 311 ii. ICD 10: F32.0, F32.1, F32.2, F32.3, F32.8, F32.9, F33.0, F33.1, F33.2, F33.3, F33.4, F33.8, F34.1 iii. Psychiatry visits defined as any of these OHIP fee codes: A195, A895, A190, A795, A695, A395, A196, A193, A194, A191, A192 iv. OMHRS: 29620-29626, 29630-29636, 31100 (major depressive disorder)</description>
          <population>This population is restricted to those who had no history of depression, thus it is a subgroup of the total study population.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="89844"/>
                <count group_id="O2" value="89844"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1750"/>
                    <measurement group_id="O2" value="1231"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <desc>Please note that only mortality from suicide was assessed, all-cause mortality could not be determined.</desc>
      <group_list>
        <group group_id="E1">
          <title>5ARI Users</title>
          <description>5ARI: Exposure to finasteride/dutasteride</description>
        </group>
        <group group_id="E2">
          <title>Non 5ARI Users</title>
          <description>Matched control patients with no exposure to 5ARI</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="160" subjects_at_risk="93197"/>
                <counts group_id="E2" subjects_affected="139" subjects_at_risk="93197"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="93197"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="93197"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="93197"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="93197"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Blayne Welk</name_or_title>
      <organization>ICES Western</organization>
      <phone>5196466000</phone>
      <email>blayne.welk@sjhc.london.on.ca</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

